• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.

作者信息

Aries James A, Davies Jeffrey K, Auer Rebecca L, Hallam Simon L, Montoto Silvia, Smith Matthew, Sevillano Belen, Foggo Vanessa, Wrench Bela, Zegocki Krzysztof, Agrawal Samir, Le Dieu Rifca, Truelove Edward, Erblich Thomas, Araf Shamzah, Okosun Jessica, Oakervee Heather, Cavenagh Jamie D, Gribben John G, Riches John C

机构信息

Department of Haemato-oncology, Barts Health NHS Trust, St. Bartholomew's Hospital, London, UK.

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.

出版信息

Br J Haematol. 2020 Jul;190(2):e64-e67. doi: 10.1111/bjh.16852. Epub 2020 Jun 10.

DOI:10.1111/bjh.16852
PMID:32420609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7276898/
Abstract
摘要

相似文献

1
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.血液肿瘤患者中2019冠状病毒病的临床结局
Br J Haematol. 2020 Jul;190(2):e64-e67. doi: 10.1111/bjh.16852. Epub 2020 Jun 10.
2
The Novel Coronavirus Outbreak: What We Know and What We Don't.新型冠状病毒疫情：我们所知道的和未知的。
Cell. 2020 Mar 19;180(6):1034-1036. doi: 10.1016/j.cell.2020.02.027. Epub 2020 Feb 19.
3
Measuring Weight with Electronic Scales in Clinical and Research Settings During the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间在临床和研究环境中使用电子秤测量体重
Obesity (Silver Spring). 2020 Jul;28(7):1182-1183. doi: 10.1002/oby.22851. Epub 2020 Jun 10.
4
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.血液系统恶性肿瘤的COVID-19患者中SARS-CoV-2 RNA的不良预后和长期持续存在；国王学院医院的经验。
Br J Haematol. 2020 Sep;190(5):e279-e282. doi: 10.1111/bjh.16935. Epub 2020 Aug 10.
5
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?托珠单抗与CAR T细胞治疗后感染风险增加无关：对COVID-19有何影响？
Blood. 2020 Jul 2;136(1):137-139. doi: 10.1182/blood.2020006216.
6
Wuhan coronavirus hunter Shi Zhengli speaks out.武汉冠状病毒追踪者石正丽发声。
Science. 2020 Jul 31;369(6503):487-488. doi: 10.1126/science.369.6503.487.
7
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?与严重急性呼吸综合征冠状病毒2感染相关的吉兰-巴雷综合征：因果关系还是巧合？
Lancet Neurol. 2020 May;19(5):383-384. doi: 10.1016/S1474-4422(20)30109-5. Epub 2020 Apr 1.
8
Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.血液系统恶性肿瘤中的冠状病毒：突破2019冠状病毒病中血管紧张素转换酶2（ACE2）屏障的靶向分子
Pathol Oncol Res. 2020 Oct;26(4):2823-2825. doi: 10.1007/s12253-020-00810-6. Epub 2020 Apr 24.
9
Obesity and COVID-19: The clash of two pandemics.肥胖与新冠疫情：两种大流行病的碰撞
Obes Res Clin Pract. 2020 Jul-Aug;14(4):380-382. doi: 10.1016/j.orcp.2020.06.003. Epub 2020 Jun 25.
10
SARS-CoV-2: The viral shedding vs infectivity dilemma.严重急性呼吸综合征冠状病毒2：病毒脱落与传染性的困境。
Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20.

引用本文的文献

1
Early combined therapy for COVID-19 in immunocompromised patients: a promising approach against viral persistence and drug resistance.免疫功能低下患者COVID-19的早期联合治疗：对抗病毒持续存在和耐药性的一种有前景的方法。
BMC Infect Dis. 2025 Apr 28;25(1):616. doi: 10.1186/s12879-025-11012-3.
2
Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters.评估 COVID-19 对急性白血病患者的影响：血液学和生化学参数的对比分析。
BMC Infect Dis. 2024 Jun 11;24(1):576. doi: 10.1186/s12879-024-09485-9.
3
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.新冠疫苗接种和奥密克戎变异株时代血液系统恶性肿瘤患者的新冠病毒病结局
Cancers (Basel). 2024 Jan 16;16(2):379. doi: 10.3390/cancers16020379.
4
Humoral and Cell-Mediated Responses to SARS-CoV-2 Vaccination in a Cohort of Immunodeficient Patients.一组免疫缺陷患者对SARS-CoV-2疫苗接种的体液和细胞介导反应
Hematol Rep. 2023 Dec 8;15(4):707-716. doi: 10.3390/hematolrep15040071.
5
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.造血细胞移植和嵌合抗原受体 T 细胞治疗患者中 SARS-CoV2 奥密克戎变异株的结局和管理。
Transplant Cell Ther. 2024 Jan;30(1):116.e1-116.e12. doi: 10.1016/j.jtct.2023.09.027. Epub 2023 Oct 6.
6
Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art.新冠病毒疫苗在肿瘤疾病患者中的有效性和安全性：最新进展
World J Clin Oncol. 2023 Sep 24;14(9):343-356. doi: 10.5306/wjco.v14.i9.343.
7
Insights into the Impact of Hesitancy on Cancer Care and COVID-19.对犹豫心理对癌症护理及新冠疫情影响的洞察
Cancers (Basel). 2023 Jun 8;15(12):3115. doi: 10.3390/cancers15123115.
8
COVID-19 in Adult Patients with Hematological Malignancies-Lessons Learned after Three Years of Pandemic.血液系统恶性肿瘤成年患者中的COVID-19——大流行三年后的经验教训
Biology (Basel). 2023 Apr 3;12(4):545. doi: 10.3390/biology12040545.
9
Cancer, more than a "COVID-19 co-morbidity".癌症，不仅仅是一种“新冠合并症”。
Front Oncol. 2023 Mar 13;13:1107384. doi: 10.3389/fonc.2023.1107384. eCollection 2023.
10
Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response.免疫功能低下患者中的新发病毒感染：更好地定义免疫反应作用的巨大挑战。
Front Immunol. 2023 Mar 9;14:1147871. doi: 10.3389/fimmu.2023.1147871. eCollection 2023.

本文引用的文献

1
Provision of cancer care during the COVID-19 pandemic.在 COVID-19 大流行期间提供癌症护理。
Nat Rev Clin Oncol. 2020 Jun;17(6):329-331. doi: 10.1038/s41571-020-0370-6.
2
Hematological findings and complications of COVID-19.COVID-19 的血液学表现及并发症。
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
3
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic.ILROG 针对 COVID-19 大流行期间血液系统恶性肿瘤放射治疗的紧急指南。
Blood. 2020 May 21;135(21):1829-1832. doi: 10.1182/blood.2020006028.
4
Acute leukemia in the time of COVID-19.新冠疫情期间的急性白血病
Leuk Res. 2020 Mar 26;92:106353. doi: 10.1016/j.leukres.2020.106353.
5
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病（COVID-19）重症患者的中性粒细胞与淋巴细胞比值及淋巴细胞与C反应蛋白比值：一项荟萃分析。
J Med Virol. 2020 Oct;92(10):1733-1734. doi: 10.1002/jmv.25819. Epub 2020 Apr 8.
6
Care of haematology patients in a COVID-19 epidemic.2019冠状病毒病疫情期间血液科患者的护理
Br J Haematol. 2020 Apr;189(2):241-243. doi: 10.1111/bjh.16620. Epub 2020 Mar 15.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.